Latest Patents News

Page 15 of 104
Alterity Therapeutics has won a new US composition of matter patent for its lead drug ATH434, extending intellectual property protection to at least 2045 and boosting its commercial potential ahead of Phase 3 trials in Multiple System Atrophy.
Ada Torres
Ada Torres
12 Aug 2026
Sparc Hydrogen has partnered with US-based SunHydrogen to integrate and test solar-driven green hydrogen modules, hitting a notable 10% solar-to-hydrogen efficiency in early trials. This collaboration aims to advance pilot-scale testing and techno-economic analysis to lower hydrogen production costs.
Maxwell Dee
Maxwell Dee
11 Aug 2026
Metal Powder Works accelerates its capacity expansion to meet surging demand in additive manufacturing and powder metallurgy, leveraging its NextGen DirectPowder™ platform and a key production order.
Maxwell Dee
Maxwell Dee
11 Aug 2026
Elk Range Mining (ASX: ELK) has kicked off its first-ever 2,850-metre diamond drilling campaign at the Friday Gold Mine in Idaho, aiming to confirm historical high-grade gold and expand resource potential using existing infrastructure.
Maxwell Dee
Maxwell Dee
11 Aug 2026
Metallium Limited has appointed key board members and executives to strengthen governance and operational capacity as it advances its Flash Joule Heating technology towards commercialisation in the US.
Maxwell Dee
Maxwell Dee
10 Aug 2026
Impact Minerals reports ultra-low uranium and thorium levels in Lake Hope high purity alumina, with three of four samples exceeding 99.99% purity. The results meet semiconductor industry standards without dedicated radionuclide removal steps, supporting ongoing pilot optimisation.
Maxwell Dee
Maxwell Dee
10 Aug 2026
EVE Health Group has progressed its Libbo pilot clinical study for erectile dysfunction with dosing set for Q4 2026 and achieved a major solubility breakthrough for apixaban, while appointing Ben Rohr as CEO to drive commercial growth.
Ada Torres
Ada Torres
7 Aug 2026
Acrux Limited spotlighted its Female Testosterone Metered Dose Transdermal System (MDTS) at the Bioshares Biotech Summit, revealing positive Phase II data and outlining a clear regulatory and commercial roadmap targeting Hypoactive Sexual Desire Disorder (HSDD) in women.
Ada Torres
Ada Torres
6 Aug 2026
Dimerix CEO Dr Nina Webster detailed the company’s geographic and product diversification at the Bioshares Summit, spotlighting the commercial potential of DMX-200 and the newly acquired Phase 2 asset DMX-652 targeting acute kidney injury.
Ada Torres
Ada Torres
6 Aug 2026
ION Video has boosted its cash runway by six months to December 2027 following a $612,498 capital injection from option exercises, while advancing commercial talks in the US.
Sophie Babbage
Sophie Babbage
4 Aug 2026
Papyrus Australia updates its timeline for delivering biodegradable fibre board to TBS Mining Solutions, following trial results that require product refinements. Commercial supply is now expected from November 2026, with acceptance testing due by September.
Victor Sage
Victor Sage
3 Aug 2026
Singular Health deepens US healthcare foothold with ongoing Triple-S contract talks, PNS licence expansion, and Miami-Dade educational rollout, supported by a solid $10.1 million cash reserve.
Victor Sage
Victor Sage
31 July 2026

Browse the archive

Full archive